about
Guidelines for the use and interpretation of assays for monitoring autophagyInhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cellsAutophagy in stem cells.Autophagy facilitates the development of breast cancer resistance to the anti-HER2 monoclonal antibody trastuzumabMetabolic control of cancer cell stemness: Lessons from iPS cellsXenohormetic and anti-aging activity of secoiridoid polyphenols present in extra virgin olive oil: a new family of gerosuppressant agentsFatty acid synthase and the lipogenic phenotype in cancer pathogenesisEpigenetics and nutrition-related epidemics of metabolic diseases: Current perspectives and challenges.Energy metabolism and metabolic sensors in stem cells: the metabostem crossroads of aging and cancer.Olive oil's bitter principle reverses acquired autoresistance to trastuzumab (Herceptin) in HER2-overexpressing breast cancer cells.tabAnti-HER2 (erbB-2) oncogene effects of phenolic compounds directly isolated from commercial Extra-Virgin Olive Oil (EVOO)Infection with HIV and HCV enhances the release of fatty acid synthase into circulation: evidence for a novel indicator of viral infectionSerum HER-2 concentration is associated with insulin resistance and decreases after weight loss.BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancer-initiating cells.Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: a pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-liContinuous administration of polyphenols from aqueous rooibos (Aspalathus linearis) extract ameliorates dietary-induced metabolic disturbances in hyperlipidemic mice.Polyphenols and the modulation of gene expression pathways: can we eat our way out of the danger of chronic disease?The Activation of the Sox2 RR2 Pluripotency Transcriptional Reporter in Human Breast Cancer Cell Lines is Dynamic and Labels Cells with Higher Tumorigenic Potential.Identification of active compounds in vegetal extracts based on correlation between activity and HPLC-MS data.Silibinin and STAT3: A natural way of targeting transcription factors for cancer therapy.Analyzing effects of extra-virgin olive oil polyphenols on breast cancer-associated fatty acid synthase protein expression using reverse-phase protein microarrays.Pediatric solid organ transplant recipients: transition to home and chronic illness care.Mammosphere formation in breast carcinoma cell lines depends upon expression of E-cadherin.The angiogenic factor CYR61 in breast cancer: molecular pathology and therapeutic perspectives.Phenolic secoiridoids in extra virgin olive oil impede fibrogenic and oncogenic epithelial-to-mesenchymal transition: extra virgin olive oil as a source of novel antiaging phytochemicals.Pro-Oxidant Activity of Amine-Pyridine-Based Iron Complexes Efficiently Kills Cancer and Cancer Stem-Like CellsLiver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histologyEpithelial-to-mesenchymal transition (EMT) confers primary resistance to trastuzumab (Herceptin).Mediterranean diet, olive oil and cancer.Transphosphorylation of kinase-dead HER3 and breast cancer progression: a new standpoint or an old concept revisited?Oncogenic properties of the endogenous fatty acid metabolism: molecular pathology of fatty acid synthase in cancer cells.Activation of the methylation cycle in cells reprogrammed into a stem cell-like state.Cancer stem cell-driven efficacy of trastuzumab (Herceptin): towards a reclassification of clinically HER2-positive breast carcinomas.Heregulin, a new interactor of the telosome/shelterin complex in human telomeres.Heregulin, a new regulator of telomere length in human cellsBasal/HER2 breast carcinomas: integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin).Anti-protozoal and anti-bacterial antibiotics that inhibit protein synthesis kill cancer subtypes enriched for stem cell-like properties.An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: Gefitinib (Iressa) -induced changes in the expression and nucleo-cytoplasmic trafficking of HER-ligands (Review).Accelerated geroncogenesis in hereditary breast-ovarian cancer syndromeRepositioning chloroquine and metformin to eliminate cancer stem cell traits in pre-malignant lesions.
P50
Q21996341-C785A60E-F71F-45D5-B3D0-0158B829AC25Q24561962-58C20174-6613-4075-9695-C8B84F2B6FF5Q26823995-DA4E9F50-8E0F-419C-B006-1D68FB95A468Q27346475-D14B4D7C-CE5A-452B-B5FD-A8D8995F5B90Q28081608-42E754C4-6A00-4F06-93B1-28F1F0D771CBQ28395443-AB07E202-6B90-4493-9DB0-E17B284BD8B0Q29615683-DA6876E0-4012-4E29-BDC4-AD3D8393E706Q30248563-9635CD38-3464-41DC-99BB-90FAB259ADB0Q30837218-4746C073-F97C-47EB-AF84-EB9AA1420752Q33284158-79713DCA-6FBC-41C1-B446-95856E5D161CQ33394374-B8CAC278-9C31-41A3-87B4-3F51F6D2FC11Q33657444-8FE4A13A-11D5-4BE3-92D9-E9A7E1EDD57BQ33737320-69C6F047-4A44-4C2B-860A-E72749DBE6ABQ33798713-DD2245FC-DA58-4BB7-BC62-C87F90D23BCDQ33990377-6A00B5DF-AE20-4E61-B768-75CDEE58667AQ34157876-BA999752-7559-4985-A170-6391767E76B0Q34402471-6B498784-A600-48C2-B99C-501ED1140067Q34452128-2E2AC00C-6067-40C5-B9F2-330BB86586D0Q34465931-E977C208-D790-4412-86D0-5011E098A9F6Q34475138-492DFABB-5E0F-472D-AED3-8B20BAFF35EBQ34657247-3CAAD64E-D74B-44DF-BCD2-DC2EBEF847A7Q34791292-6D70A2F0-055A-44CC-85A1-9812E38C7E08Q35017138-8C1F7042-1047-4109-BB1D-CFA866941BB1Q35147091-EEA5CCF0-2E3B-4931-8814-63B20FB158ECQ35770306-C3E5A544-26A0-4635-8D31-58095215C48DQ35773665-AEDA0DED-6F80-4281-9627-7212AD34E4F2Q35783949-25E51C4A-FBFF-4A10-88A4-13B7340712EAQ36426509-33D007F0-DED9-4F30-AC05-30B90CAB389FQ36457057-7997FC41-2B92-450E-B122-A65495ACDF80Q36458755-0CF0B561-DF0E-4EE8-A2E6-F5E57E8BF0CCQ36508454-BF09DE44-64CB-47E4-8778-92B9BB46E28BQ36527529-B81B38B0-4B76-4BDD-951A-1F5A4BF4ADFDQ36544839-8BD4085F-42C4-48AE-ACA9-82B54A1D8D62Q36545398-EEDC448E-2C4E-4048-9A9A-2081EEC6AD5EQ36545401-76FE73C7-2AD6-4359-B087-5C65455BD4E6Q36618624-9F823CBC-7251-48E8-AC8E-DA8BF3D00103Q36781090-54B61856-9B8B-404F-BF83-7F23660326BDQ36840684-D969B55B-45DA-4CA1-A0C7-7A8169585D28Q37022075-1F7318C5-4DEF-45BE-AF60-C40694E889FAQ37091483-F83ABD8F-3104-4FB8-8D8A-EBF05B5ACD51
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Javier A Menendez
@ast
Javier A Menendez
@en
Javier A Menendez
@es
Javier A Menendez
@nl
type
label
Javier A Menendez
@ast
Javier A Menendez
@en
Javier A Menendez
@es
Javier A Menendez
@nl
prefLabel
Javier A Menendez
@ast
Javier A Menendez
@en
Javier A Menendez
@es
Javier A Menendez
@nl
P108
P106
P108
P21
P31
P496
0000-0001-8733-4561